Federal award
WERFEN USA LLC
N0025922F0233
Contract
Obligated and Ceiling
- Obligated (net)
- $223,928.56
- Ceiling (potential value, not spending)
- $223,928.56
- Current value
- $223,928.56
- Gross positive obligations
- $223,928.56
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- WERFEN USA LLC · JA87HT8KP2M2
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- WERFEN USA LLC · JA87HT8KP2M2
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N0025922F0233
- Parent vehicle (IDV PIID)
- V797D70110
- Award type code
- C
- Actions
- 10 · Sep 9, 2022 to Jan 22, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 22, 2026 | FY2026 | P00009 | C | $55,982.14 | — |
| Jun 27, 2025 | FY2025 | P00008 | G | $0.00 | — |
| May 8, 2025 | FY2025 | P00007 | M | $0.00 | — |
| Nov 17, 2024 | FY2025 | P00006 | C | $55,982.14 | — |
| Sep 12, 2024 | FY2024 | P00005 | G | $0.00 | — |
| Nov 7, 2023 | FY2024 | P00004 | C | $55,982.14 | — |
| Sep 14, 2023 | FY2023 | P00003 | G | $0.00 | — |
| Nov 2, 2022 | FY2023 | P00002 | C | $55,982.14 | — |
| Sep 29, 2022 | FY2022 | P00001 | B | $0.00 | — |
| Sep 9, 2022 | FY2022 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.